Selonterra Inc is a pioneering company based in San Mateo, CA, dedicated to fundamentally transforming therapies for neurodegenerative disorders by harnessing human genetics and gene regulatory networks.
With a unique approach that links human genetics and gene expression networks, Selonterra Inc identifies unexploited targets for therapy development, focusing on small molecule drugs that modulate key mediators of neurodegeneration to enhance accessibility and convenience for patients.
Generated from the website